CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol. 2021;27(2):295-304.   Published online 2020 December 3    DOI: https://doi.org/10.3350/cmh.2020.0216

Excel Download

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Clinical and Molecular Hepatology. 2021;27(2):295-304   Crossref logo
Link1 Link2 Link3

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Clinical and Molecular Hepatology. 2021;27(2):273-277   Crossref logo
Link1 Link2 Link3

Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?
The Korean Journal of Gastroenterology. 2019;74(1):66   Crossref logo
Link1 Link2 Link3

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B
Alimentary Pharmacology & Therapeutics. 2020;52(5):911-912   Crossref logo
Link1 Link2

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors’ reply
Alimentary Pharmacology & Therapeutics. 2020;52(5):913-914   Crossref logo
Link1 Link2

Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis
Alimentary Pharmacology & Therapeutics. 2007;26(3):383-391   Crossref logo
Link1 Link2

Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
European Journal of Internal Medicine. 2021;84:68-73   Crossref logo
Link1 Link2

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
Viruses. 2017;9(5):96   Crossref logo
Link1

THU-231-Risk of hepatocellular carcinoma in patients with immune-tolerant chronic hepatitis B
Journal of Hepatology. 2019;70(1):e266-e267   Crossref logo
Link1 Link2

P1-089: Hepatocellular carcinoma occurrence and recurrence during and post direct acting antiviral treatments of real-life chronic hepatitis C patients in Mongolia
Journal of Viral Hepatitis. 2018;25:69-69   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.